|
For the fourth year in a row, Pharmaceutical Executive slices and dices the numbers to learn who's really on top.
Sep 1, 2005
By:
Bill Trombetta
Not surprisingly, the biotechs hold three of the top five rankings in percent of sales invested in R&D. Even more impressive, then, are the ratios for Big Pharmas like Schering-Plough and Eli Lilly, in third and fourth place, both at a bit more than 19 percent.
|
Running the Numbers on Pharma's Top Performers
Sep 1, 2004
By:
Bill Trombetta
In 2002, pharma had three of the top 10 profit makers: Pfizer, Merck, and Johnson & Johnson.
In 2003, not a single pharma company placed
in the top 10 corporate profit earners.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
